X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (170) 170
index medicus (100) 100
oncology (86) 86
arabinonucleosides - therapeutic use (78) 78
arabinonucleosides - pharmacokinetics (72) 72
male (69) 69
clofarabine (67) 67
arabinonucleosides - administration & dosage (66) 66
adult (63) 63
female (61) 61
hematology (61) 61
pharmacology & pharmacy (53) 53
arabinonucleosides - adverse effects (52) 52
middle aged (52) 52
arabinonucleosides - pharmacology (49) 49
animals (48) 48
pharmacokinetics (47) 47
aged (46) 46
antineoplastic agents - therapeutic use (46) 46
acute myeloid-leukemia (44) 44
adenine nucleotides - administration & dosage (43) 43
child (43) 43
adenine nucleotides - therapeutic use (39) 39
leukemia (39) 39
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (38) 38
treatment outcome (38) 38
leukemia, myeloid, acute - drug therapy (34) 34
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
pediatric-patients (31) 31
adenine nucleotides - adverse effects (30) 30
adolescent (29) 29
adenine nucleotides - pharmacokinetics (27) 27
antineoplastic agents - pharmacokinetics (27) 27
article (26) 26
cancer (25) 25
chemotherapy (25) 25
recurrence (25) 25
antineoplastic agents - pharmacology (24) 24
children (24) 24
arabinonucleosides - chemistry (23) 23
metabolism (23) 23
adults (22) 22
child, preschool (22) 22
dose-response relationship, drug (22) 22
phase-i (22) 22
ribonucleotide reductase (22) 22
antimitotic agents (21) 21
antineoplastic agents (21) 21
cytarabine (21) 21
nelarabine (21) 21
transplantation (21) 21
young adult (21) 21
clinical trials as topic (20) 20
cytosine - analogs & derivatives (20) 20
acute myelogenous leukemia (19) 19
adenine nucleotides (19) 19
deoxycytidine kinase (19) 19
nucleoside analog (19) 19
phase-ii (19) 19
2-chloro-9-adenine (18) 18
acute lymphoblastic-leukemia (18) 18
adenine nucleotides - pharmacology (18) 18
therapy (18) 18
antineoplastic agents - adverse effects (17) 17
chronic lymphocytic-leukemia (17) 17
nucleoside analogs (17) 17
remission induction (17) 17
research (17) 17
drug administration schedule (16) 16
fludarabine (16) 16
hematology, oncology and palliative medicine (16) 16
mice (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
arabinonucleosides - blood (15) 15
health aspects (15) 15
neoplasms - drug therapy (15) 15
pediatrics (15) 15
antineoplastic agents - administration & dosage (14) 14
cells (14) 14
dna (14) 14
hematopoietic stem cells (14) 14
prognosis (14) 14
vidarabine - analogs & derivatives (14) 14
acute lymphoblastic leukemia (13) 13
aged, 80 and over (13) 13
antimetabolites, antineoplastic - therapeutic use (13) 13
arabinonucleosides - metabolism (13) 13
care and treatment (13) 13
drug resistance, neoplasm (13) 13
infant (13) 13
leukemia - drug therapy (13) 13
myelodysplastic syndrome (13) 13
acute myeloid leukemia (12) 12
antitumor-activity (12) 12
busulfan (12) 12
cytarabine - administration & dosage (12) 12
cytosine - therapeutic use (12) 12
leukemia, myeloid, acute - therapy (12) 12
medicine & public health (12) 12
pharmacology/toxicology (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2011, Volume 51, Issue 5, pp. 679 - 686
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2011, Volume 29, Issue 24, pp. 3293 - 3300
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 12/2017, Volume 58, Issue 12, pp. 2865 - 2874
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2011, Volume 67, Issue 4, pp. 875 - 890
Clofarabine for injection is a second-generation nucleoside analog approved in the United States (Clolar®) and Europe (Evoltra®) for the treatment of pediatric... 
Hybrid estimation | Modeling and simulation | Medicine & Public Health | Oncology | Cancer Research | Nucleoside | Imputation | Renal impairment | Pharmacology/Toxicology | NONMEM | CELLS | MODEL | CLADRIBINE | PREDICTION | CHILDREN | GLOMERULAR-FILTRATION-RATE | INHIBITION | ONCOLOGY | CREATININE | PHARMACOLOGY & PHARMACY | 2-CHLORO-9-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)ADENINE | LEUKEMIA | Body Weight | Age Factors | Humans | Middle Aged | Child, Preschool | Half-Life | Biological Availability | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Young Adult | Adenine Nucleotides - pharmacokinetics | Arabinonucleosides - administration & dosage | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacokinetics | Adenine Nucleotides - administration & dosage | Child | Administration, Oral | Adenine Nucleotides - therapeutic use | Creatinine - urine | Arabinonucleosides - therapeutic use | Neoplasms - drug therapy | Arabinonucleosides - pharmacokinetics | Models, Biological | Adolescent | Creatinine - blood | Aged | Neoplasms - pathology | Pediatric pharmacology | Antimitotic agents | Cancer patients | Metabolites | Analysis | Leukemia | Nucleosides | Models | Adults | Children | Antineoplastic agents | Health aspects
Journal Article
Journal Article
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 2009, Volume 78, Issue 11, pp. 1351 - 1359
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2015, Volume 75, Issue 5, pp. 897 - 906
Journal Article